Biotech Blog

18 March 2004

Drug Prices: The Genentech Solution

Drug Prices: The Genentech Solution
“If developed nations want access to breakthrough medicines, they should have to pay full price, says Genentech Chief Executive Arthur D. Levinson. “

No Comments currently posted.

Post a comment on this entry:

Name required

Mail (will not be published) required

Website

•  
  
   
  

• Similar Posts

  • Abbott Gets Tough with Thailand
  • Genentech’s CEO on Big Pharma’s Issues
  • 7 drug makers unveil elderly discounts
  • Genentech Will Ride Out Drug Failure
  • Price controls and compulsory licensing give buyers more power … for a price.

• Recent Posts

  • Seeking reviewers and contributors for next edition of Building Biotechnology
  • Dyadic founder fights to regain control of company
  • Drug Patent Expirations in May 2008
  • Why so quiet?
  • Journal of Commercial Biotechnology — March 2008

• Recent Comments

  • mohammed Filali on Seeking reviewers and contributors for next edition of Building Biotechnology
  • smaranya.com » Blog Archive » Seeking reviewers and contributors for next edition of Building Biotechnology on Contact
  • Biotech Blog » Seeking reviewers and contributors for next edition of Building Biotechnology on Contact
  • smaranya.com » Journal of Commercial Biotechnology — March 2008 on Journal of Commercial Biotechnology — March 2008
  • Guido Cavakliere on Want biotechnology venture capital? Use a shotgun!

• Links

  • Biotechnology Career Development
  • Biotechnology Case Studies
  • Biotechnology Glossary
  • Introduction to Molecular Biology
  • Pharmaceutical Innovation Dashboard

• Other Biotech Blogs

  • BioHealth Investor
  • Colorado Life Science Deal Flow
  • Drug Wonks
  • FasterCures
  • GMO Africa Blog
  • In the Pipeline
  • Patent Baristas
  • Pharma Marketing Blog
  • Pharmalot
  • The Biotech Weblog

• Meta

  • Register
  • Log in
  • Entries RSS
  • Comments RSS
  • WordPress.org